6505-00-933-8704 ( NDC00039-0055-25 , LASIX INJECTION , NDC00074-6102-02 , NDC00641-0382-25 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-00-933-8704 | 6505 | 009338704 | FUROSEMIDE INJECTION,USP | 3004 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00039-0055-25 | 04500 | F | 2 | 3 | 6 | 54 | |
| LASIX INJECTION | 04500 | F | 1 | 5 | 6 | 54 | |
| NDC00074-6102-02 | 60060 | A | 2 | 3 | 6 | 54 | |
| NDC00641-0382-25 | 51968 | A | 2 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00039-0055-25 | 04500 | HOECHST-ROUSSEL PHARMACEUTICALS | A | F |
| LASIX INJECTION | 04500 | HOECHST-ROUSSEL PHARMACEUTICALS | A | F |
| NDC00074-6102-02 | 60060 | ABBOTT LABORATORIES INC. | A | A |
| NDC00641-0382-25 | 51968 | ELKINS-SINN INC | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 08/23/1 | P | 3004909165 | 3004 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 2 ML |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 1 | VI | Q | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|